Last reviewed · How we verify
Placebo of Reference product
Placebo of Reference product is a Small molecule drug developed by FLUIDDA nv. It is currently in Phase 3 development. Also known as: Placebo inhaler containing HFA propellant resembling the reference active inhaler.
A placebo formulation designed to match the physical and sensory characteristics of a reference product for blinded clinical trial comparison.
At a glance
| Generic name | Placebo of Reference product |
|---|---|
| Also known as | Placebo inhaler containing HFA propellant resembling the reference active inhaler |
| Sponsor | FLUIDDA nv |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert formulations used in controlled clinical trials to serve as a comparator arm against an active drug. This particular placebo is manufactured by FLUIDDA nv to mimic the reference product's appearance, taste, texture, and administration method, enabling double-blind study design while the actual therapeutic mechanism is attributable to the reference product being tested, not the placebo itself.
Approved indications
Common side effects
Key clinical trials
- Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI (NA)
- A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis (PHASE3)
- A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris (PHASE1)
- A Study Evaluating Quality of Life Parameters Following Use of Emergen-C (PHASE4)
- A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer (PHASE1, PHASE2)
- Glycyrrhetinic Acid and Acute Irritant Dermatitis (NA)
- Evaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth (PHASE3)
- Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Reference product CI brief — competitive landscape report
- Placebo of Reference product updates RSS · CI watch RSS
- FLUIDDA nv portfolio CI
Frequently asked questions about Placebo of Reference product
What is Placebo of Reference product?
How does Placebo of Reference product work?
Who makes Placebo of Reference product?
Is Placebo of Reference product also known as anything else?
What development phase is Placebo of Reference product in?
Related
- Manufacturer: FLUIDDA nv — full pipeline
- Also known as: Placebo inhaler containing HFA propellant resembling the reference active inhaler
- Compare: Placebo of Reference product vs similar drugs
- Pricing: Placebo of Reference product cost, discount & access